Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

A hypothalamus-habenula circuit controls aversion.

Lazaridis I, Tzortzi O, Weglage M, Märtin A, Xuan Y, Parent M, Johansson Y, Fuzik J, Fürth D, Fenno LE, Ramakrishnan C, Silberberg G, Deisseroth K, Carlén M, Meletis K.

Mol Psychiatry. 2019 Sep;24(9):1351-1368. doi: 10.1038/s41380-019-0369-5. Epub 2019 Feb 12.

PMID:
30755721
2.

Four Unique Interneuron Populations Reside in Neocortical Layer 1.

Schuman B, Machold RP, Hashikawa Y, Fuzik J, Fishell GJ, Rudy B.

J Neurosci. 2019 Jan 2;39(1):125-139. doi: 10.1523/JNEUROSCI.1613-18.2018. Epub 2018 Nov 9.

3.

Functional Differentiation of Cholecystokinin-Containing Interneurons Destined for the Cerebral Cortex.

Calvigioni D, Máté Z, Fuzik J, Girach F, Zhang MD, Varro A, Beiersdorf J, Schwindling C, Yanagawa Y, Dockray GJ, McBain CJ, Hökfelt T, Szabó G, Keimpema E, Harkany T.

Cereb Cortex. 2017 Apr 1;27(4):2453-2468. doi: 10.1093/cercor/bhw094.

4.

Integration of electrophysiological recordings with single-cell RNA-seq data identifies neuronal subtypes.

Fuzik J, Zeisel A, Máté Z, Calvigioni D, Yanagawa Y, Szabó G, Linnarsson S, Harkany T.

Nat Biotechnol. 2016 Feb;34(2):175-183. doi: 10.1038/nbt.3443. Epub 2015 Dec 21.

5.

Protracted brain development in a rodent model of extreme longevity.

Penz OK, Fuzik J, Kurek AB, Romanov R, Larson J, Park TJ, Harkany T, Keimpema E.

Sci Rep. 2015 Jun 29;5:11592. doi: 10.1038/srep11592.

6.

Endocannabinoids modulate cortical development by configuring Slit2/Robo1 signalling.

Alpár A, Tortoriello G, Calvigioni D, Niphakis MJ, Milenkovic I, Bakker J, Cameron GA, Hanics J, Morris CV, Fuzik J, Kovacs GG, Cravatt BF, Parnavelas JG, Andrews WD, Hurd YL, Keimpema E, Harkany T.

Nat Commun. 2014 Jul 17;5:4421. doi: 10.1038/ncomms5421.

7.

Miswiring the brain: Δ9-tetrahydrocannabinol disrupts cortical development by inducing an SCG10/stathmin-2 degradation pathway.

Tortoriello G, Morris CV, Alpar A, Fuzik J, Shirran SL, Calvigioni D, Keimpema E, Botting CH, Reinecke K, Herdegen T, Courtney M, Hurd YL, Harkany T.

EMBO J. 2014 Apr 1;33(7):668-85. doi: 10.1002/embj.201386035. Epub 2014 Jan 27.

8.

Long-acting beneficial effect of percutaneously intramyocardially delivered secretome of apoptotic peripheral blood cells on porcine chronic ischemic left ventricular dysfunction.

Pavo N, Zimmermann M, Pils D, Mildner M, Petrási Z, Petneházy Ö, Fuzik J, Jakab A, Gabriel C, Sipos W, Maurer G, Gyöngyösi M, Ankersmit HJ.

Biomaterials. 2014 Apr;35(11):3541-50. doi: 10.1016/j.biomaterials.2013.12.071. Epub 2014 Jan 16.

9.

Unexpected effects of peripherally administered kynurenic acid on cortical spreading depression and related blood-brain barrier permeability.

Oláh G, Herédi J, Menyhárt A, Czinege Z, Nagy D, Fuzik J, Kocsis K, Knapp L, Krucsó E, Gellért L, Kis Z, Farkas T, Fülöp F, Párdutz A, Tajti J, Vécsei L, Toldi J.

Drug Des Devel Ther. 2013 Sep 16;7:981-7. doi: 10.2147/DDDT.S44496. eCollection 2013.

10.

A simple novel technique to induce short-lasting local brain ischaemia in the rat.

Knapp L, Gellért L, Herédi J, Kocsis K, Oláh G, Fuzik J, Kis Z, Vécsei L, Toldi J, Farkas T.

Neuropathol Appl Neurobiol. 2014 Aug;40(5):603-9. doi: 10.1111/nan.12069.

PMID:
23795719
11.

Fundamental interstrain differences in cortical activity between Wistar and Sprague-Dawley rats during global ischemia.

Fuzik J, Gellért L, Oláh G, Herédi J, Kocsis K, Knapp L, Nagy D, Kincses ZT, Kis Z, Farkas T, Toldi J.

Neuroscience. 2013 Jan 3;228:371-81. doi: 10.1016/j.neuroscience.2012.10.042. Epub 2012 Oct 26.

PMID:
23103797
12.

Kainate postconditioning restores LTP in ischemic hippocampal CA1: onset-dependent second pathophysiological stress.

Nagy D, Kocsis K, Fuzik J, Marosi M, Kis Z, Teichberg VI, Toldi J, Farkas T.

Neuropharmacology. 2011 Oct-Nov;61(5-6):1026-32. doi: 10.1016/j.neuropharm.2011.07.005. Epub 2011 Jul 19.

PMID:
21781978
13.

Neuroprotection with a new kynurenic acid analog in the four-vessel occlusion model of ischemia.

Gellért L, Fuzik J, Göblös A, Sárközi K, Marosi M, Kis Z, Farkas T, Szatmári I, Fülöp F, Vécsei L, Toldi J.

Eur J Pharmacol. 2011 Sep 30;667(1-3):182-7. doi: 10.1016/j.ejphar.2011.05.069. Epub 2011 Jun 12.

PMID:
21664350
14.

Oxaloacetate restores the long-term potentiation impaired in rat hippocampus CA1 region by 2-vessel occlusion.

Marosi M, Fuzik J, Nagy D, Rákos G, Kis Z, Vécsei L, Toldi J, Ruban-Matuzani A, Teichberg VI, Farkas T.

Eur J Pharmacol. 2009 Feb 14;604(1-3):51-7. doi: 10.1016/j.ejphar.2008.12.022. Epub 2008 Dec 24.

PMID:
19135048

Supplemental Content

Support Center